Guido van Amerongen Selected Research

PF-06273340

1/2018

Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guido van Amerongen Research Topics

Disease

9	Pain (Aches) 01/2020 - 01/2016
2	Neuralgia (Stump Neuralgia) 08/2019 - 10/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Long Term Adverse Effects 01/2019
1	Chronic Pain 01/2018
1	Hyperalgesia 10/2016
1	Burns 10/2016

Drug/Important Bio-Agent (IBA)

8	Analgesics (Analgesic Drugs)IBA 01/2020 - 01/2016
5	Pregabalin (Lyrica)FDA Link 01/2020 - 01/2017
4	Ibuprofen (Motrin)FDA LinkGeneric 01/2020 - 01/2017
1	Sodium Channels (Sodium Channel)IBA 01/2020
1	PF-05089771IBA 01/2020
1	Sodium Channel BlockersIBA 01/2020
1	PF-06372865IBA 08/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019
1	seltorexantIBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	PF-06273340IBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	EsketamineIBA 01/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2017
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2016
1	N-Methylaspartate (NMDA)IBA 10/2016
1	Opioid Analgesics (Opioids)IBA 10/2016
1	Capsaicin (Zostrix)FDA Link 10/2016

Therapy/Procedure

1	Analgesia 01/2018